Vernon M. Camp

1.4k total citations
47 papers, 1.1k citations indexed

About

Vernon M. Camp is a scholar working on Cellular and Molecular Neuroscience, Biochemistry and Molecular Biology. According to data from OpenAlex, Vernon M. Camp has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 14 papers in Biochemistry and 13 papers in Molecular Biology. Recurrent topics in Vernon M. Camp's work include Amino Acid Enzymes and Metabolism (13 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Metabolism and Genetic Disorders (11 papers). Vernon M. Camp is often cited by papers focused on Amino Acid Enzymes and Metabolism (13 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Metabolism and Genetic Disorders (11 papers). Vernon M. Camp collaborates with scholars based in United States and Switzerland. Vernon M. Camp's co-authors include Bahjat A. Faraj, Mark M. Goodman, Eugene Malveaux, Larry Williams, Jeffrey J. Olson, J Chipponi, Jonathan McConathy, John R. Votaw, Laurent Martarello and Clinton D. Kilts and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Vernon M. Camp

47 papers receiving 1.1k citations

Peers

Vernon M. Camp
Eugene Malveaux United States
Dennis J. Pillion United States
F. H. Leibach United States
Peter R Bernstein United States
Susan A. Gregory United States
Eugene Malveaux United States
Vernon M. Camp
Citations per year, relative to Vernon M. Camp Vernon M. Camp (= 1×) peers Eugene Malveaux

Countries citing papers authored by Vernon M. Camp

Since Specialization
Citations

This map shows the geographic impact of Vernon M. Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon M. Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon M. Camp more than expected).

Fields of papers citing papers by Vernon M. Camp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernon M. Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon M. Camp. The network helps show where Vernon M. Camp may publish in the future.

Co-authorship network of co-authors of Vernon M. Camp

This figure shows the co-authorship network connecting the top 25 collaborators of Vernon M. Camp. A scholar is included among the top collaborators of Vernon M. Camp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernon M. Camp. Vernon M. Camp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nye, Jonathon A., John R. Votaw, J. Douglas Bremner, et al.. (2014). Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans. Nuclear Medicine and Biology. 41(3). 217–222. 11 indexed citations
2.
Ning, Xinghai, Seungjun Lee, Kiyoko Takemiya, et al.. (2014). PET Imaging of Bacterial Infections with Fluorine‐18‐Labeled Maltohexaose. Angewandte Chemie International Edition. 53(51). 14096–14101. 111 indexed citations
3.
Weber, Collin J., Susan Müller, Susan A. Safley, et al.. (2013). Expression of functional folate receptors by human parathyroid cells. Surgery. 154(6). 1385–1393. 7 indexed citations
4.
Nye, Jonathon A., David M. Schuster, Bital Savir-Baruch, et al.. (2011). Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid. Nuclear Medicine and Biology. 38(7). 1035–1041. 2 indexed citations
5.
Jarkas, Nachwa, Ronald J. Voll, Vernon M. Camp, Zhaobin Zhang, & Mark M. Goodman. (2010). Characterization of the two enantiomers of anti-18F-FACPC as PET tumor agents. Nature Communications. 51(1). 1516–1516. 4 indexed citations
6.
Yu, Weiping, Larry Williams, Vernon M. Camp, Jeffrey J. Olson, & Mark M. Goodman. (2010). Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma. Bioorganic & Medicinal Chemistry Letters. 20(7). 2140–2143. 27 indexed citations
7.
Yu, Weiping, Larry Williams, Vernon M. Camp, et al.. (2009). Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorganic & Medicinal Chemistry. 17(5). 1982–1990. 32 indexed citations
8.
Nye, Jonathon A., John R. Votaw, Nachwa Jarkas, et al.. (2008). Compartmental Modeling of11C-HOMADAM Binding to the Serotonin Transporter in the Healthy Human Brain. Journal of Nuclear Medicine. 49(12). 2018–2025. 18 indexed citations
9.
Zeng, Fanxing, Jeffrey S. Stehouwer, Nachwa Jarkas, et al.. (2007). Synthesis and biological evaluation of 2β,3α-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents. Bioorganic & Medicinal Chemistry Letters. 17(11). 3044–3047. 3 indexed citations
10.
Jarkas, Nachwa, John R. Votaw, Ronald J. Voll, et al.. (2005). Carbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters. Nuclear Medicine and Biology. 32(3). 211–224. 22 indexed citations
11.
McConathy, Jonathan, Laurent Martarello, Eugene Malveaux, et al.. (2003). Synthesis and evaluation of 2-amino-4-[18F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids. Nuclear Medicine and Biology. 30(5). 477–490. 25 indexed citations
12.
Faraj, Bahjat A., et al.. (1994). The effect of cocaine abuse on plasma levels of sulfated dopamine and salsolinol in alcoholics. Alcohol. 11(4). 337–342. 2 indexed citations
13.
Faraj, Bahjat A., et al.. (1994). Platelet Monoamine Oxidase Activity in Alcoholics, Alcoholics with Drug Dependence, and Cocaine Addicts. Alcoholism Clinical and Experimental Research. 18(5). 1114–1120. 26 indexed citations
14.
Faraj, Bahjat A., et al.. (1993). Elevated concentrations of dopamine sulfate in plasma of cocaine abusers. Biochemical Pharmacology. 46(8). 1453–1457. 9 indexed citations
15.
Faraj, Bahjat A., Vernon M. Camp, & Michael Kutner. (1991). Interrelationship between Activation of Dopaminergic Pathways and Cerebrospinal Fluid Concentration of Dopamine Tetrahydroisoquinoline Metabolite Salsolinol in Humans: Preliminary Findings. Alcoholism Clinical and Experimental Research. 15(1). 86–89. 9 indexed citations
16.
Pais, Ray, et al.. (1990). Abnormal vitamin B6 status in childhood leukemia. Cancer. 66(11). 2421–2428. 11 indexed citations
17.
Faraj, Bahjat A., et al.. (1989). Elevation of Plasma Salsolinol Sulfate in Chronic Alcoholics as Compared to Nonalcoholics. Alcoholism Clinical and Experimental Research. 13(2). 155–163. 36 indexed citations
18.
Faraj, Bahjat A., et al.. (1987). Prevalence of Low Monoamine Oxidase Function in Alcoholism. Alcoholism Clinical and Experimental Research. 11(5). 464–467. 47 indexed citations
19.
Faraj, Bahjat A., et al.. (1984). Development of a sensitive radioassay of histamine for in vitro allergy testing.. PubMed. 25(1). 56–63. 19 indexed citations
20.
Faraj, Bahjat A., et al.. (1977). The measurement of 3-o-methyldopamine in urine and plasma by a rapid and specific radioimmunoassay.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(10). 1027–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026